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Abstract
The growing availability of multi-omic data provides a highly comprehensive view
of cellular processes at the levels of mRNA, proteins, metabolites, and reaction fluxes.
However, due to probabilistic interactions between components depending on the envi-
ronment and on the time course, casual, sometimes rare interactions may cause impor-
tant effects in the cellular physiology. To date, interactions at the pathway level cannot
be measured directly, and methodologies to predict pathway cross-correlations from re-
action fluxes are still missing. Here, we develop a multi-omic approach of flux-balance
analysis combined with Bayesian factor modeling with the aim of detecting pathway
cross-correlations and predicting metabolic pathway activation profiles. Starting from
gene expression profiles measured in various environmental conditions, we associate a
flux rate profile with each condition. We then infer pathway cross-correlations and
identify the degrees of pathway activation with respect to the conditions and time
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course using Bayesian factor modeling. We test our framework on the most recent
metabolic reconstruction of Escherichia coli in both static and dynamic environments,
thus predicting the functionality of particular groups of reactions and how it varies
over time. In a dynamic environment, our method can be readily used to characterize
the temporal progression of pathway activation in response to given stimuli.
Keywords
Multi-omics, Flux Balance Analysis, Escherichia coli, Bayesian factor modeling, Pathway
correlation, Temporal pathway activation
1 Introduction
The recent availability of high-throughput data regarding multiple layers of biological orga-
nization (“omics”) allows mapping cellular processes at the levels of mRNA, proteins, and
metabolites. Analogously, the growing number of defined pathways, where reactions are
classified into groups, allows us to better understand the particular functionality achieved
by a series of reactions. To date, the study of interactions between pathways taken as single
entities has been already applied to genes through gene expression analysis (1 ). Such in-
teractions, also known as pathway cross-correlations, are important to produce appropriate
response to external stimuli, and are assumed to be the underlying mechanism describing
the response to dynamic environments. This suggests that studying biological systems re-
quires a holistic approach that takes the concerted activities of molecules into account (2 ).
Previous studies inferred cross-correlations from gene expression data (3 –5 ) and others from
protein-protein networks (6 ). Another recent study applied a Bayesian network inference to
identify causal relationships among the most influential reactions (7 ). However, methods to
infer cross-correlations between pathways from reaction fluxes, and therefore making use of
the metabolism and its reaction-pathway associations, are still missing.
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In the last 25 years, high-quality genome-scale reconstructions of metabolic networks
have been combined with constraint-based optimization in order to analyze microorganisms
at steady state. To improve the predicting capability of a metabolic model, one can include
multiple ‘omic’ layers, such as gene expression, codon usage, protein abundance, and the
interaction between these layers. The interdependence among gene expression levels, protein
production and growth rate has been analyzed thoroughly by Scott et al. (8 ), highlighting a
linear relation between the RNA-protein ratio and the growth rate of the bacterium. Other
methodologies regarding how to improve the model predictions by means of gene expression
have been recently proposed (9 ).
Arguably, flux-balance analysis (FBA) is the most widely used constraint-based tech-
nique to predict flux distributions and network capabilities in large biochemical networks
(10 ). FBA has proved useful thanks to its ability to handle large networks: it requires in-
formation about biochemical reactions and stoichiometric coefficients, but does not involve
kinetic parameters. This makes it well suited to studies that enumerate and characterize
perturbations such as different substrates or genetic interventions (e.g. knockouts) leading
to obligatory coupling between the growth rate and the production of a desired metabolite
(11 ). Recently, more than 1000 prokaryotic genomes have been fully sequenced, thus al-
lowing FBA models to incorporate also information on enzymes and genome, including the
relationships among genes, proteins and reactions (GPR mapping). To date, more than 90
genome-wide metabolic reconstructions have been published (12 ).
In this study, we propose a methodology to predict the cellular response to environmental
conditions from a pathway-based perspective. The classification of metabolic reactions into
pathways allows us to understand or predict the functionality of particular groups of reactions
under given growth conditions. However, since the interactions at the pathway level cannot
be measured directly, we propose to apply a hierarchical Bayesian framework, which supports
latent variable models in order to take pathway information into account (5 ). We focus
on the cellular activity of Escherichia coli on the genomic, fluxomic and pathway levels
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in different environmental settings by integrating an augmented metabolic model with a
machine learning technique applied at the fluxomic level. Integrating a FBA model and a
Bayesian factor model leads to determining the degree of metabolic pathway responsiveness
and to detecting pathway cross-correlations, starting from gene expression profiles (Figure
1).
The aim of this paper is to combine a Bayesian machine learning technique and a multi-
omic flux model augmented with gene expression profiles in order to integrate and analyze
data representing heterogeneous biological levels of organization. Our method highlights
complex interactions between components of the model at different layers. We start with
the investigation of the genome scale model by using metabolic flux analysis in a bilevel set-
ting, namely the maximization of growth rate and acetate production. Through a Bayesian
factor approach, we detect pathway cross-correlations that are assumed to be a static, in-
trinsic property of E. coli underlying its response behavior. Furthermore, we infer pathway
activation profiles as a bacterial response to an ensemble of environmental conditions. Fi-
nally, we use time series of gene expression profiles combined with our hybrid approach in
order to investigate changing pathway responsiveness.
2 Flux-balance analysis with continuous gene expres-
sion
Flux-balance analysis (FBA) is a linear programming technique that models the steady state
condition in a chemical reaction network (13 ). The combination of flux-balance constraints
and capacity constraints on the metabolic fluxes is a system of linear homogeneous equations
and inequalities, thus its solution space is a convex polyhedral cone representing the feasible
flux distributions. The flux-balance constraint is represented by the equation dX/dt = Sv =
0, where X represents the vector of the concentrations of all metabolites of the network,
S its stoichiometric matrix, and v the vector of flux rates. This constraint can be thought
4
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Figure 1: Our modeling framework combines Bayesian machine learning and metabolic flux
modeling to analyze metabolic pathways from gene expression data. First, we propose an
augmented FBA method (M1) to map gene expression data (A) on the metabolic network
(B). The method includes a bilevel maximization framework in the case study of biomass-
acetate objective space, therefore producing optimal flux profiles in different environmental
conditions (C). Using a set of conditions with time-series gene expression profiles, we use our
framework to elucidate the metabolism dynamics, involving rearrangements in the objective
space during growth (D). Finally, we perform Bayesian factor modeling (M2) on the reaction
flux distribution, by taking pre-defined reaction-pathway memberships as prior knowledge.
This enables us to infer the pathway responsiveness to each environmental condition (E)
and the cross-correlations between pathways (F), elucidating the underlying mechanisms of
bacterial response to dynamically changing environments.
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of as Kirchoff’s laws applied to any node representing a metabolite in the network. The
flux through a metabolite must be constant, namely the input flux equals the output flux.
If one allows the concentrations of metabolites to increase linearly, the conditions become
dX/dt ≥ 0, which is equivalent to Sv ≥ 0. This approach represents Von Neumann’s
optimal growth scenario, and may be useful when one has to ensure that some metabolites
are available also outside of the chemical reaction network modeled (e.g. when modeling only
a compartment of a larger organism (14 ), or when applying external optimization algorithms
to maximize or minimize the metabolite concentration (15 )).
To analyze the effects caused by the change of external media and conditions in which
an E. coli strain was grown, we map each gene expression array (microarray profiles) to the
acetate-biomass space of objective functions. We take these two fluxes as objectives because
of the common assumption that microorganisms tend to optimize their metabolic network
in order to maximize the growth rate, and possibly produce additional chemicals, in order
to cope with multiple, sometimes conflicting, objectives to optimize simultaneously (16 ). As
well as being an important target for biotechnology, with multiple industrial applications
(17 ), acetate is central to many pathways in both aerobic and anaerobic E. coli. Being an
intermediate metabolite, it is representative of processes not directly related to growth, and
therefore it is highly indicative of metabolic flexibility for possible reorganizations that need
to be performed during adaptations to environmental changes. When acetate is present at
high levels, it inhibits cell growth and recombinant protein productivity (18 ).
The gene regulation process in bacteria is used to respond to the variations taking place
in the metabolism or in the external environment. Here we take into account 466 E. coli
Affymetrix Antisense2 microarray expression profiles collected in various media and condi-
tions (19 ), such as low or high glucose, aerobic or anaerobic environment, pH changes, an-
tibiotics, and heat shock. For the dynamical analysis of growth, we will consider 41 growth
conditions, each of which has been sampled at four time steps (164 microarray profiles in
total).
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Each expression profile is mapped to the E. coli model (20 ), which we have augmented
with a map from gene expression (GE) to constraints for metabolic fluxes. First, in order
map a gene expression profile to a gene set expression (GSE) profile, we use recursively the
following rules valid for the three basic cases of gene set:
Single gene: GSE(g) = GE(g),
Enzymatic complex: GSE(g1 ∧ g2) = min{GE(g1),GE(g2)},
Isozymes: GSE(g1 ∨ g2) = max{GE(g1),GE(g2)}.
(1)
Then, we solve the two-level maximization problem
max gᵀv
such that max
{
fᵀv
∣∣Sv = 0, vi ≥ V mini h(yi), vi ≤ V maxi h(yi)} (2)
where V mini and V
max
i are the default lower- and upper-bound for each flux vi, f and g
are n-dimensional Boolean arrays that select the fluxes to be maximized (in this paper, only
one flux is selected for each level of the maximization problem). The gene set expression
yi = GSEi represents the “expression” of the ith reaction of the model. The map from each
gene set to the associated flux upper- and lower-bound is defined as
h(x) =
γ(1 + |log(x)|)sgn(x−1)
σ2i
(3)
(and h(x) = γ/σ2i if x = 1), where sgn(x − 1) = (x − 1)/ |x− 1|; γ is the weight for the
variance σ2, which is the variance of the gene set, computed from the variance of its genes
using the same rules (1) used for the gene set expression (Figure 1-M1).
The importance of a gene - and therefore the ability to change the reaction flux of the
corresponding reaction in the FBA model - is inversely proportional to the variance of that
gene across all the experimental conditions. The idea underlying this assumption is that
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those genes whose expression is only slightly varied across conditions must be regarded as
key genes for the organism (21 ). We adopt γ as a multiplicative factor for the inverse of
the variance of each gene, representing the weight attributed to the variance as an indicator
of the importance of a gene. Here, γ was chosen as the value that causes the smallest loss
of information (quantified using a normalized root mean square error, NRMSE) when using
the Bayesian factor model. However, if further experimental data is available (e.g. protein
abundance, translation rate, codon usage or post-translational modifications), we expect this
parameter to be varied individually for each reaction.
The reasons for choosing this mathematical structure are as follows. First, a recent
model suggests a protein synthesis rate growing fast with increasing mRNA abundance,
but decreasing the growth speed for high values of mRNA abundance (22 ). Second, there
is empirical evidence that logarithmic maps are useful to map biological processes (23 ).
Third, the approximation of this behavior with a logarithmic function simplifies the task of
avoiding that unrealistically high values of measured gene expression levels are translated into
overly weak constraints. The correlation between gene expression and metabolic phenotype
is still a matter of debate, but recent evidence suggests that protein abundance is mainly
determined by the transcript level (24 , 25 ). Therefore, we use the logarithmic map only to
set constraints, while we solve the bilevel linear program (2) to find the final flux distribution
under each condition. The solution of the bilevel problem is a pair representing the maximum
natural objective (biomass) allowed by the constraints, and the maximum second objective
(acetate) possible in the computed biomass-maximizing flux distribution. Each experimental
condition is associated with a gene expression array, and therefore with a bilevel problem.
3 Pathway-based Bayesian factor modeling
Factor modeling is an unsupervised learning technique in a family of latent variable mod-
els, assuming that high-dimensional data are generated from the hidden lower-dimensional
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factors that are shared across data samples. Specifically, matrix factorization assumes that
an observed R×C data matrix can be explained by two low-rank matrices with the dimen-
sion of R × P and P × C where P << R,C. Moreover, under Gaussian Markov Random
Field (GMRF) properties, assuming a Gaussian distribution on the underlying factors in the
matrix factorization process can capture the dependency between each element in P .
Here we regard pathways as the latent factors underlying bacterial flux responses. We
assume that the observed flux rates arise from specific combinations of pathways that are
activated by a stimulus. In particular, the values of a flux rate for each reaction depends on
the degrees of pathway activation and on the association strength between that reaction and
the activated pathways. Having obtained the R × C flux rate matrix from the bilevel FBA
where R and C are the number of reactions and conditions respectively, we use the Bayesian
matrix factorization modeling with GMRF to perform pathway analysis. Specifically, we
decompose the flux rate data matrix into two low-rank matrices whose dimensions are R×P
and P ×C, as well as a P ×P correlation matrix, where P is the number of latent pathways.
Note that, in general, we take a pathway into account if it is associated with at least one
reaction in R. Figure 1-M2 demonstrates the factor model graphically and mathematically.
On the basis of the rationale of matrix factorization, the R × P matrix represents the
association strength between reaction fluxes and pathways, while the P ×C matrix denotes
the association strength between pathways and conditions, suggesting degrees of pathway
responsiveness. In addition, the correlations between metabolic pathways are denoted by
the P × P matrix.
Formally, let R,C, and P be the number of reactions, conditions, and pathways respec-
tively. The flux data matrix X ∈ RR×C is decomposed into two matrices: X ∼ BS. The
first matrix B ∈ RR×P denotes the membership strength of reactions in each pathway. The
second matrix S ∈ RP×C corresponds to the degree of pathway responsiveness specific to
each condition. We transform the pre-defined reaction-pathway memberships of the E. coli
model into the binary matrix K ∈ {0, 1}R×P in order to guide the clustering of reactions
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into pathways in B. On the basis of our assumption of pathway cross-correlations, we model
pathway dependencies by assuming a Gaussian distribution on S with a zero mean and a pre-
cision (inverse covariance) matrix Φ ∈ RP×P from which the correlations between pathways
are computed.
Based on the Gaussian Markov Random Field (GMRF) framework, the off-diagonal ele-
ments of the precision (inverse covariance) matrix can be interpreted as the partial correla-
tions between any two random variables as follows (26 ). The zero pattern in the precision
matrix encodes the independence relations of two variables generated by a Gaussian distribu-
tion conditioned on the other random variables. Therefore, the precision matrix can be used
to form a pathway cross-correlation network, where nodes represent individual pathways
and neighboring nodes represent highly correlated pathways. More precisely, since we as-
sume that for any given condition c, the pathway responsiveness vector sc ∼ Normal(0,Φ−1)
is randomly drawn from a P -dimensional multivariate Gaussian with a zero mean µ and
a precision matrix Φ, we can form an undirected graph G(Φ) = (V,E) with vertices V
corresponding to the random variables (pathways) V1, V2, V3, . . . , VP and edges E satisfying
(Vi, Vj) ∈ E if and only if φij 6= 0. If N (i) = j : (i, j) ∈ E denotes the set of neighboring
nodes of s in the graph G, the independence correlation of Vi ⊥ Vu|VN (i) holds for any node
u 6∈ N (i) that is not a neighbor of Vi. Moreover, the correlation strength between Vi and Vj
is calculated as
Corr(Vi, Vj|V\ij) =
∣∣∣∣∣ φij√φiiφjj
∣∣∣∣∣ , (4)
where the subscript “\ij” indicates all nodes except Vi and Vj. Consequently, the corre-
lation strength will range from zero to one, indicating the weakest correlation (conditional
independence) and strongest correlation respectively. The remarkable characteristic of the
GMRF is that the conditional independence can be interpreted directly from the precision
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matrix. More importantly, it can encode any arbitrary structure of a graph.
Having observed the data matrix X, the goal is to make inference on S,B, and Φ. Our
interest for biological interpretation is only on S and Φ, which indicate the degree of pathway
responsiveness to each condition and the cross-correlations between pathways, respectively.
At each time step, we use the inferred cross-correlations as the underlying mechanism of the
E. coli system to predict the temporal progression of pathway activation.
In order to infer all unknown variables, we apply a Bayesian approach starting from the
construction of a full probabilistic model, in which all relevant entities (i.e. observed data,
latent variables, and nuisance variables) are treated as random variables having uncertainties
described by a probability distribution. To avoid the optimization of the parameters, we ap-
ply the Bayesian hierarchical modeling, in which each parameter is given a prior distribution
with a set of fixed hyperparameters.
The model is mainly based on Gaussian distributions containing two parameters, a mean
and a precision (an inverse variance). According to the matrix factorization method, X is
modeled with a mean BS and a precision τ (Equations (5) and (6)).
xrc =
P∑
p=1
brpspc +  = brsc +  ;  = random noise,  ∈ R, (5)
 ∼ Normal(0, τ−1 ) (6)
where br is the rth row of B, and sc is the cth column of S. Equations (7) and (8) illustrate
that the latent variables B and S are modeled with a zero mean because of the sparsity con-
straints. While elements in B are assumed to be independently distributed with a precision
τB, elements in S are presumably correlated within each column with a precision matrix Φ,
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expressing the hypothesis of pathway cross-correlations.
brp =

0, if krp = 0
Normal(brp|0, τ−1B ), if krp = 1
(7)
sc ∼ GMRF(0,Φ−1) (8)
All parameters (τ, τB, and Φ) are given conjugate priors with their own fixed hyperparam-
eters (α, β, αB, βB, ν,Ψ), which are a Gamma distribution for τ and τB and a Wishart
distribution for Φ (Equation (9),(10) and (11)).
τ ∼ Gamma(α, β) (9)
τB ∼ Gamma(αB, βB) (10)
Φ ∼Wishart(ν,Ψ) (11)
The set of Equation (5) - (11) entirely specifies each model entity with its probability dis-
tribution (5 ). The use of conjugate priors makes the inference computable analytically.
Upon the model specification, inference of unknown quantities can be made through the
computation of the posterior distribution, which is composed by the probability conditioned
on the observed data, known as likelihood, and its prior. Due to the conjugacy, we apply
a Gibbs sampling algorithm, where each unknown variable is alternately sampled until the
convergence is satisfactory. In order to reduce auto-correlation between samples, every ten
iterations, we collect the samples of the matrix S for the comparison between conditions over
time, and those of Φ for the analysis of pathway cross-correlations.
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4 Results and discussion
We first applied FBA modeling to map 466 gene expression data profiles, plus 164 time-
series data profiles, into 2583 reaction flux rates of the E. coli metabolic network, subject to
the maximization of acetate and biomass production. Next, we performed Bayesian factor
modeling on those reaction fluxes by taking pre-defined reaction-pathway memberships as
prior knowledge to infer the responsiveness degree of the 37 pathways of the E. coli model.
4.1 Sensitivity and mean square error analysis
Based on a normalized root mean square error (NRMSE) as shown in Equation (12), we
performed a convergence analysis indicating how well the model fits the data. We compute
the error as
NRMSE =
√∑
r,c
(xrc − brsc)2/(R× C)
xmax − xmin , (12)
where xmax and xmin are the highest and lowest values in X.
More specifically, the NRMSE indicates how much the estimated flux rates inferred from
the model assumption according to Equation (5) are deviated from the original flux rate data
matrix. In other words, it intuitively represents the information loss we expect if we use this
model in place of the actual flux rates. The smaller the error is, the better the model fits
the data. Figure 2 shows that the error decreases to approximately 0.853% at the stationary
state.
We also performed a sensitivity analysis on γ in order to show the robustness of our
approach, by testing the perturbation of the flux rates induced by various perturbations
of γ. Specifically, small changes of γ (1%) caused a very small average perturbation of
0.0079 mmolh−1gDW−1 of the flux rates, 0.024 mmolh−1gDW−1 for acetate and 0.0009 h−1
for biomass. A stronger (10%) perturbation of γ yields an average perturbation of 0.0081
13
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Figure 2: Normalized root mean square error (NRMSE) across the iterations.
mmolh−1gDW−1 of the flux rates, 0.2200 mmolh−1gDW−1 for acetate and 0.0085 h−1 for
biomass. Finally, a strong perturbation (one order of magnitude) resulted in an average
change of 0.2385 mmolh−1gDW−1 in the flux rates, 2.0696 mmolh−1gDW−1 for acetate, and
0.044 h−1 for biomass. We would like to remark that γ can be assigned individually for
each reaction where information on the translation rate, codon usage or post-translational
modifications is available.
4.2 Bacterial flux responses and pathway cross-correlations
With the objective to maximize both biomass and acetate production as shown in Figure
3, the E. coli strains grown in conditions with 10 mmolh−1gDW−1 of glucose uptake rate
produce more biomass and acetate than the strains in lower glucose. Under aerobic condi-
tions, the maximum biomass is 2.31 h−1 with 39.52 mmol h−1 gDW−1 of acetate, while the
maximum acetate reached is 48.20 mmol h−1 gDW−1 with a biomass of 2.16 h−1. Under
anaerobic conditions and low glucose, the maximum biomass is 1.04 h−1 (with 4.36 mmol
h−1 gDW−1 of acetate production). Under anaerobic conditions and high glucose, the E. coli
is only able to produce 1.36 h−1 of biomass, with a maximum of 19.50 mmol h−1 gDW−1
of acetate. The full table with the experimental conditions and the values of acetate and
biomass are in Supplementary Information. We are interested in investigating the underly-
ing mechanisms in different oxygen conditions and glucose uptake rates (high/low glucose
environments with a threshold of 10 mmolh−1gDW−1).
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Figure 3: Through augmented FBA, all the 466 gene expression profiles are mapped to the
acetate-biomass objective space. Each point contains 2583 reaction flux rates, while only
acetate and biomass are shown, representing the objectives of the bilevel linear program.
The color bar shows the glucose uptake rate [mmolh−1gDW−1]. Interestingly, the E. coli
grown in some conditions with 10 mmolh−1gDW−1 of glucose uptake rate is able to produce
more biomass and acetate than the strains grown on higher glucose. The pathway-based
Bayesian analysis is performed on the flux rates in the four conditions based on the two
criteria of oxygen and glucose.
The Bayesian factor modeling with GMRF allows us to extract the behaviors of E. coli
in response to a variety of experimental conditions and cross-correlations between pathways.
Since we assume that the pathway cross-correlations represent a static, intrinsic property
of E. coli, the model computes the cross-correlations as a global factor which is shared by
individual conditions and over time. Figure 4 illustrates the sparse network of inferred cross-
correlations between metabolic pathways. It is remarkable that nucleotide pathway (PID:5)
acts as a central hub of the cross-correlation network, and is involved with multiple path-
ways. The strongest correlation is the cross-correlation between the alanine and aspartate
metabolism pathway (PID:25) and the pivot pathway of another small community pertaining
to the valine, leucine, and isoleucine metabolism (PID:17). A recent review of amino acids
and their functions shows that alanine is the primary amino acid gluconeogenesis, and valine
directly synthesizes glutamine and alanine (27 ).
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Interestingly, there is a modest link between these two clusters PID:5 and PID:17 with
correlation ≈ 0.15 (top 3% in the correlation matrix) by a transcription factor called leucine-
responsive regulatory protein (Lrp) (28 ). This link plays an important role depending on
the availability of oxygen over time, which we will discuss in the next section. Table 1 shows
the average responsiveness degree of the most responsive pathways to different oxygen and
glucose conditions. While the nucleotide pathway is important under anaerobic conditions
on low glucose, the valine, leucine, and isoleucine metabolism pathway and the alanine and
aspartate metabolism pathway both exhibit a key role under aerobic conditions on high
glucose, highlighting a pathway cross-correlation between them (Figure 4).
Table 1: Average responsiveness of the most responsive pathways across aerobic and anaer-
obic conditions of high and low glucose. PID:5 is important under anaerobic conditions on
low glucose, while PID:17 and PID:25 both exhibit a key role under aerobic conditions on
high glucose, highlighting a pathway cross-correlation between them.
High glucose Low glucose
PID Pathway name Aerobic Anaerobic Aerobic Anaerobic
5 Nucleotide salvage 0.0865 0.0965 0.1366 0.1714
17 Valine, leucine, and isoleucine metabolism 0.2219 0.2147 0.1974 0.1590
25 Alanine and aspartate metabolism 0.1544 0.1487 0.1285 0.1076
4.3 Flux rate progression and temporal pathway activation
Not only do the E. coli strains respond to the environment differently from condition to
condition within the same time frame, but their temporal behaviors also progress over time
in a different way. In order to perform a dynamical analysis of pathway activation, we
consider the gene expression profiles of 41 time-course experiments after the exposure to
stimuli or in stress conditions.
Figure 5 shows the acetate secretion/assimilation and the growth rate as a result of the
metabolic regulation system of Escherichia coli in response to the changing environment. We
also compare the Euclidean distance “covered” by each of the 41 conditions from the start to
the end of the observations (four time steps). The fluctuations in acetate production depend
on the balance between pyruvate fermentation to acetate and Krebs cycle. Interestingly, the
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Figure 4: Pathway correlation matrix derived from Φ, an output of the Bayesian factor mod-
eling. On the y-axis we report the pathway identifiers (PID) that correspond to their pathway
names labeled on the diagonal. The color bar shows the correlation between pathways com-
puted with the Bayesian factor modeling. These values suggest the strength of pathway
cross-correlations underlying the bacterial response through flux rates in both steady-state
and time-course experiments.
most remarkable fluctuations are those caused by the presence of ampicillin, norfloxacin and
spectinomycin, antibiotics used to treat a number of bacterial infections. This result confirms
that in specific conditions, some antibiotics can have a high impact on the metabolism and
physiology of E. coli, while others (e.g. kanamycin) have no effect (for instance, due to the
development of antimicrobial resistance). These metabolic transitions confirm well-known
experimental results on the acetate switch during growth under different conditions, and on
the inverse relation between growth rate and acetate secretion (29 , 30 ). The global response
of the biomass to a changing environment can be explained also as a separated response of
two subpopulations reacting at different speeds to the environmental change (31 ).
Pathway activation shows an apparent progress over time in the aerobic condition shown
in Figure 6a, while the anaerobic activation is more static (Figure 6b). As expected, the
nucleotide salvage pathway (PID:5) highly responds to the environment where oxygen was
present, while valine, leucine, and isoleucine metabolism pathway (PID:17) and alanine and
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Figure 5: Acetate production/assimilation and biomass produced by Escherichia coli in 41
different environmental conditions. We used a set of 164 expression arrays consisting of 41
conditions with 4 measurements each. Growth conditions include pH changes, antibiotics,
genetic perturbations, heat shock, different growth media, carbon source, oxygen and glucose
concentrations (see Supplementary Information for further details). Some conditions show
quick metabolic rearrangement during growth, whereas under other conditions the bacterium
metabolism remains stable. In the right panel, we show the Euclidean distance covered by
each of the 41 conditions in the biomass-acetate space during the four time steps. The
conditions whose bars are not shown have a negligible (less than 10−9) distance covered in
the acetate-biomass space during the four time steps.
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Figure 6: Pathway responsiveness in four conditions: (a) aerobic, (b) anaerobic, (c) high
glucose, and (d) low glucose at four time steps. We performed the Bayesian factor modeling
on the time-course flux rate responses sharing the same underlying cross-correlations. As
a result, pathway responsiveness indicates how much a pathway is likely to be responsive
to a given condition at a given time. The pathway responsiveness plots provide us the
comprehensive interpretation of the E. coli progression of phenotypic behavior in response
to each condition, as shown in the plots at the bottom. Specifically, conditions with large
variations in the biomass and acetate production are also likely to cause large variation in
the pathway responsiveness.
aspartate metabolism (PID:25) are less active. In contrast, all these pathways are active
in response to the low-oxygen environments, and maintain their activity over time. These
results support the inferred cross-correlation between two communities of PID:5 and PID:17
linked by the transcription factor called leucine-responsive regulatory protein (Lrp) (28 ),
which is designated as a global transcription factor in E. coli (32 ). A recent experiment
confirmed that the activity of Lrp decreases as aerobiosis increases (33 ). This may explain
the mechanism of the inactive PID:17 after the exposure to oxygen.
In addition, we observed that the cysteine metabolism pathway (PID:21) was activated
in the anaerobic condition and lasted for three time steps before it was deactivated in the last
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time point. The case of cysteine has long been studied in bacteria: although cysteine residues
of FNR, another global transcription factor in E. coli (32 ), are alkylated with iodoacetate
in permeabilized aerobic or anaerobic conditions, the process takes 50 minutes in anaerobic
bacteria and 6 minutes in aerobic bacteria (34 ). Thus, we could not observe that the cysteine
metabolism was active at any time steps after six minutes in aerobic bacteria, but we could
observe the activation of cysteine pathway at the first three time frames within the first 50
minutes under anaerobic condition.
Different levels of glucose uptake also change pathway activities over time as shown in
Figures 6c and 6d. At the early stage of glucose prevalence, the methylglyoxal metabolism
pathway (PID:12) was activated, unlike when the bacterium was starved of glucose. Methyl-
glyoxal (MG) is usually synthesized under a condition with low phosphate and high dihy-
droxyacetone phosphate (DHAP), an environment that occurs most frequently under high-
glucose settings (35 ). A recent experiment confirmed that the increase of glucose uptake
rates result in the temporary excretion of methylglyoxal synthase (MgsA) (36 , 37 ). As MG
accumulation will lead to cell death, E. coli requires a mechanism for MG degradation (37 ).
The detoxification of methylglyoxal includes the conversion MG to S-lactoyl glutathione and
then to D-lactate by glyoxalase enzymes I and II (37 ). This procedure has also been pre-
sented to be the predominant MG detoxification system in E. coli (37 , 38 ). This exposition
also endorses our discovery about the modest correlation (≈ 0.05) between the methylgly-
oxal metabolism pathway (PID:12) and the glyoxalase metabolism pathway (PID:35), which
appears at the top 10% of the inferred sparse cross-correlation network.
5 Conclusion
As a result of many recent research efforts to elucidate the relation between genotype and
phenotype, we currently have models for a better understanding of the individual compo-
nents, but arguably a less clear picture of the interactions between the biological components
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that result in a given phenotype (10 ). We still have, moreover, limited knowledge about how
to use these models to predict a phenotypic response to a changing environmental condi-
tion, due to the lack of comprehensive data across different conditions and accurate training
processes performed on the models (39 ). Probabilistic, sometimes rare interactions between
molecules and metabolic activation depend on external conditions and may change over time.
These interactions and active components give rise to important effects in the bacterial phys-
iology, such as non-linear activation of toggle switches or master regulators.
When a particular bacterial phenotype has to be achieved, some pathways are required to
respond more than others. Our idea is to analyze a compendium of experimental conditions
to investigate the combinations of pathway activation that will allow the bacterium to mimic
the behavior of the desired phenotype. In order to map the environmental changes to the
E. coli, we started from the most recent genome-scale metabolic reconstruction (20 ) and we
used bilevel flux-balance-analysis to modify the constraints on the metabolic fluxes according
to the gene expression profile associated with each condition. Each environmental condition
is converted into a flux profile and mapped to a single point in a bidimensional objective
space, therefore translating dynamic genetic activities into dynamic reactions fluxes. (In this
paper we focused on the acetate-biomass space, but the methodology is readily applicable
to any multidimensional space by extending bilevel FBA to many-level FBA.)
At this step, thousands of reaction flux rates for each experimental condition would
need a lot of expertise and manual work for their interpretation. We therefore summarized
the reaction fluxes by developing a Bayesian factor model able to identify the pathway re-
sponsiveness, representing the responsive degree of each pathway under each environmental
condition. Our method is also able to achieve a systematic prediction of E. coli metabolic
pathway responses to time-varying signals. The Bayesian factor model simultaneously eluci-
dates all the pathway-pathway interactions (pathway cross-correlations), which are also the
underlying process behind the pathway activation at each time step. While the activation of
some metabolic pathways is kept at the same level, other pathways fluctuate as part of the
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global response to the fluctuating environment.
While the cross-correlations are considered an intrinsic property of the E. coli metabolic
network, and thus being computed globally, the degrees of responsiveness depend on the
particular environmental conditions at each time step. This characterizes the temporal
progression of pathway activation, throughout the time series, in response to given stimuli.
Instead of considering a single condition a time, performing the analysis across all conditions
provides insights into pathway connectivity and pathway islands that rarely co-activate with
others. Pathway activation profiles allows different conditions in which the E. coli responds
similarly to be clustered. This is also advantageous for discovering alternative antibiotic
treatments by replacing stimuli with different chemicals (40 ). Many interesting applications
can be implemented from the particular pathway cross-correlations predicted from a set of
environmental experiments. For instance, they facilitate the prediction of bacterial behaviors
in specific situations involving reciprocal action or influence between different organisms, e.g.
the interaction between bacteria and plants in mycorrhiza, or sepsis and health conditions
(e.g. gut microbiota). Our results can also help to shed light on why different conditions
can show the same response in a given multi-objective output space. Finally, assessing
the pathway correlations with our framework can indicate an operating distance between
pathways, thus enhancing the current knowledge of the metabolic network and providing
foundations of methodological value for analyzing multi-omic data.
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